PUNE, India - The report "Microcrystalline Cellulose Market by Application (Food & Beverage, Pharmaceutical, Cosmetics & Personal Care, and Others), by Raw Material Source (Wood based and Non-Wood ...

Austin, April 01, 2026 (GLOBE NEWSWIRE)-- The Microcrystalline Cellulose Market size was estimated at USD 1.30 billion in 2025 and is expected to reach USD 2.61 billion by 2035, growing at a CAGR of 7 ...

NEW YORK & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)-- Asahi Kasei, a diversified Japanese multinational company, has completed the construction of its second plant for Ceolus™ microcrystalline ...

The global microcrystalline cellulose market is projected to grow at a CAGR of 6.23% during 2026–2031, with Asia-Pacific emerging as the fastest-growing region, supported by expanding pharmaceutical ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Microcrystalline Cellulose Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's ...

The direct transformation of cellulose, which is the main component of lignocellulosic biomass, into building-block chemicals is the key to establishing biomass-based sustainable chemical processes.

Sigachi Industries stocks made a bumper listing on the Bombay Stock Exchange on Monday. The shares of cellulose-based ...

TOKYO--(BUSINESS WIRE)--Asahi Kasei's Specialty Solutions SBU will build a second plant for microcrystalline cellulose [1] (trade name Ceolus™) at its Mizushima Works in Kurashiki, Okayama, Japan.

The growth of the market is driven by increasing pharmaceutical solid dosage form production, expanding clean-label food and beverage formulation requirements, and ...

Asahi Kasei currently manufactures Ceolus™, a microcrystalline cellulose used primarily in pharmaceuticals as tablet binder [2], in Nobeoka, Miyazaki, Japan. Besides the standard-type product PH ...